Skip to main content
. 2020 Jan 2;12(1):121. doi: 10.3390/cancers12010121

Figure 3.

Figure 3

Tumor hypoxia and perfusion in response to RT fractionation schedule. (A) Immunohistological staining for hypoxia (pimonidazole) and perfusion (Hoechst 33342) two weeks after RT initiation in PC3 and LLC tumors. (B,C) Quantification of hypoxia in PC3 (B) and LLC (C) tumors at day 15. (D,E) Quantification of Hoechst perfusion in PC3 (D) and LLC (E) tumors at day 15. Images and analysis represent two independent experiments with a total ≥18 PC3 and ≥15 LLC tumors per point. * indicates p < 0.05.